share_log

Humana (NYSE:HUM) Shares Gap Down After Analyst Downgrade

Humana (NYSE:HUM) Shares Gap Down After Analyst Downgrade

Humana (紐約證交所代碼:HUM) 分析師降級後股票差距下降
Defense World ·  2023/02/03 02:31

Humana Inc. (NYSE:HUM – Get Rating) gapped down before the market opened on Thursday after TheStreet downgraded the stock from a b rating to a c+ rating. The stock had previously closed at $513.28, but opened at $499.13. Humana shares last traded at $492.19, with a volume of 245,244 shares traded.

在華爾街將Humana Inc.的股票評級從B級下調至C+級後，Humana Inc.(NYSE：HUM-GET Rating)週四開盤前股價下跌。該股此前收盤報513.28美元，開盤報499.13美元。Humana的股票最新報492.19美元，總成交量為245,244股。

A number of other equities analysts have also commented on the stock. Cowen raised their price objective on shares of Humana from $547.00 to $647.00 in a research report on Monday, November 7th. Truist Financial lifted their target price on shares of Humana from $570.00 to $650.00 in a research note on Thursday, November 3rd. Royal Bank of Canada boosted their price objective on shares of Humana from $560.00 to $637.00 and gave the company an "outperform" rating in a research report on Thursday, November 3rd. JPMorgan Chase & Co. dropped their target price on shares of Humana from $630.00 to $625.00 and set an "overweight" rating on the stock in a report on Friday, January 6th. Finally, Cowen upped their price target on shares of Humana from $547.00 to $647.00 in a research note on Monday, November 7th. Two investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Humana has an average rating of "Moderate Buy" and an average price target of $608.75.

其他一些股票分析師也對該股發表了評論。考恩在11月7日週一的一份研究報告中將Humana的股票目標價從547.00美元上調至647.00美元。Truist Financial在11月3日週四的一份研究報告中將Humana的目標股價從570.00美元上調至650.00美元。加拿大皇家銀行將Humana的股價目標從560.00美元上調至637.00美元，並在11月3日週四的一份研究報告中給出了該公司“跑贏大盤”的評級。摩根大通將Humana股票的目標價從630.00美元下調至625.00美元，並在1月6日星期五的一份報告中對該股設定了“增持”評級。最後，考恩在11月7日週一的一份研究報告中將Humana的目標股價從547.00美元上調至647.00美元。兩名投資分析師對該股的評級為持有，12名分析師給出了買入評級，一名分析師對該公司發出了強烈的買入評級。根據MarketBeat的數據，Humana的平均評級為“中等買入”，平均目標價為608.75美元。

Get
到達
Humana
哈門那
alerts:
警報：

Insider Buying and Selling at Humana

Humana的內幕買賣

In other Humana news, CEO Bruce D. Broussard sold 7,000 shares of the firm's stock in a transaction dated Monday, December 12th. The stock was sold at an average price of $531.92, for a total value of $3,723,440.00. Following the completion of the sale, the chief executive officer now owns 65,602 shares of the company's stock, valued at $34,895,015.84. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, insider Timothy S. Huval sold 635 shares of Humana stock in a transaction that occurred on Friday, December 16th. The stock was sold at an average price of $497.71, for a total transaction of $316,045.85. Following the completion of the transaction, the insider now directly owns 4,968 shares in the company, valued at $2,472,623.28. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Bruce D. Broussard sold 7,000 shares of the business's stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $531.92, for a total value of $3,723,440.00. Following the completion of the sale, the chief executive officer now owns 65,602 shares of the company's stock, valued at $34,895,015.84. The disclosure for this sale can be found here. Insiders have sold 22,635 shares of company stock worth $11,565,286 over the last quarter. Insiders own 0.39% of the company's stock.

在Humana的其他新聞中，首席執行官布魯斯·D·布魯薩德在12月12日星期一的交易中出售了7000股公司股票。這隻股票的平均售價為531.92美元，總價值為3723,440.00美元。出售完成後，首席執行官現在擁有65,602股公司股票，價值34,895,015.84美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過此超鏈接。在相關新聞中，內部人士蒂莫西·S·休瓦爾在12月16日星期五的一筆交易中出售了635股Humana股票。該股以497.71美元的平均價格出售，總成交金額為316,045.85美元。交易完成後，這位內部人士現在直接擁有該公司4968股，價值2,472,623.28美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可以通過此超鏈接。此外，首席執行官布魯斯·D·布魯薩德在12月12日星期一的一次交易中出售了7000股該公司的股票。這些股票的平均價格為531.92美元，總價值為3,723,440.00美元。出售完成後，首席執行官現在擁有65,602股公司股票，價值34,895,015.84美元。關於這次銷售的披露可以找到這裏。在上個季度，內部人士已經出售了22,635股公司股票，價值11,565,286美元。內部人士持有該公司0.39%的股份。

Institutional Trading of Humana

Humana的制度性交易

Large investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Humana by 1.3% during the third quarter. Vanguard Group Inc. now owns 11,181,313 shares of the insurance provider's stock worth $5,425,061,000 after buying an additional 147,619 shares during the last quarter. FMR LLC lifted its stake in Humana by 0.6% during the 2nd quarter. FMR LLC now owns 6,753,633 shares of the insurance provider's stock worth $3,161,173,000 after acquiring an additional 40,087 shares in the last quarter. State Street Corp increased its holdings in Humana by 1.0% during the 3rd quarter. State Street Corp now owns 5,613,554 shares of the insurance provider's stock worth $2,728,012,000 after purchasing an additional 53,899 shares during the period. Bank of New York Mellon Corp increased its holdings in Humana by 63.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,692,255 shares of the insurance provider's stock worth $821,065,000 after purchasing an additional 654,681 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Humana by 0.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,126,002 shares of the insurance provider's stock worth $546,388,000 after purchasing an additional 5,926 shares during the period. 93.38% of the stock is currently owned by hedge funds and other institutional investors.
大型投資者最近對他們在該公司的頭寸進行了調整。先鋒集團第三季度增持Humana股份1.3%。先鋒集團(Vanguard Group Inc.)目前持有11,181,313股這家保險公司的股票，價值5,425,061,000美元，上季度又購買了147,619股。FMR LLC在第二季度增持了Humana 0.6%的股份。FMR LLC目前擁有這家保險公司6,753,633股股票，價值3,161,173,000美元，上個季度又收購了40,087股。道富銀行在第三季度增持了Humana 1.0%的股份。道富集團目前持有這家保險公司5,613,554股股票，價值2,728,012,000美元，在此期間又購買了53,899股。紐約梅隆銀行(Bank Of New York Mellon Corp)第三季度增持Humana股份63.1%。紐約梅隆銀行(Bank Of New York Mellon Corp)目前持有這家保險公司1,692,255股股票，價值821,065,000美元，在此期間又購買了654,681股。最後，Dimension Fund Advisors LP在第三季度增加了對Humana的持有量0.5%。Dimension Fund Advisors LP在此期間額外購買了5926股，現在擁有這家保險提供商價值546,388,000美元的股票1,126,002股。93.38%的股票目前由對衝基金和其他機構投資者持有。

Humana Trading Down 4.6 %

Humana股價下跌4.6%

The company has a market cap of $62.00 billion, a PE ratio of 22.21, a P/E/G ratio of 1.30 and a beta of 0.72. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.48. The company has a fifty day simple moving average of $511.66 and a two-hundred day simple moving average of $506.00.

該公司市值620.億美元，市盈率22.21，市盈率1.30，貝塔係數0.72。該公司的流動比率為1.35，速動比率為1.35，債務權益比率為0.48。該公司的50日簡單移動均線切入位在511.66美元，200日簡單移動均線切入位在506.00美元。

Humana (NYSE:HUM – Get Rating) last announced its earnings results on Wednesday, February 1st. The insurance provider reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.46 by $0.16. The firm had revenue of $22.44 billion during the quarter, compared to analysts' expectations of $22.45 billion. Humana had a return on equity of 19.99% and a net margin of 3.07%. The business's revenue was up 6.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.24 EPS. Analysts anticipate that Humana Inc. will post 25.05 EPS for the current year.

Humana(NYSE：HUM-GET Rating)最近一次公佈收益結果是在2月1日星期三。這家保險公司公佈本季度每股收益(EPS)為1.62美元，高於分析師普遍預期的1.46美元和0.16美元。該公司當季營收為224.4億美元，高於分析師預期的224.5億美元。Humana的股本回報率為19.99%，淨利潤率為3.07%。該業務的收入同比增長了6.6%。去年同期，該公司每股收益為1.24美元。分析師預計Humana Inc.將公佈本年度每股收益25.05美元。

Humana Company Profile

Humana公司簡介

(Get Rating)

(獲取評級)

Humana Inc engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts.

Humana Inc.從事醫療保險服務的提供。該公司通過以下部門經營：零售、集團和專業以及醫療保健服務。零售部分包括以零售方式銷售給個人的產品，包括醫療和補充計劃，如聯邦醫療保險，以及基於州的合同。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Humana (HUM)
  • Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
  • Mullen Automotive Stock Gains Momentum On Positive News
  • Harley-Davidson Inc. Stock, Is It Time To Buy?
  • The Bottom Is In For Meta Platforms, Volatility Is Not Over
  • Analyzing Alaska Air's Recent Earnings
  • 免費獲取StockNews.com關於Humana的研究報告(嗡嗡)
  • 凱西·伍茲的方舟創新ETF將在2023年反彈？
  • 馬倫汽車公司股票因利好消息而上漲
  • 哈雷-戴維森公司的股票，是時候買入了嗎？
  • Meta平臺的底部已經到了，波動性還沒有結束
  • 阿拉斯加航空公司近期收益分析

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

接受《Humana Daily》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Humana和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論